A chart review of the ordering and documentation of urine toxicology screens in a cancer center: Do they influence patient management?

Journal of Pain and Symptom Management

Volumn 19, Issue 1, 2000, Pages 40-44

  Passik, Steven D ^a   Schreiber, Jennifer ^b   Kirsh, Kenneth L ^c   Portenoy, Russell K ^d  

^a Oncology Symptom Control Research   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c INDIANA UNIVERSITY   (United States)

^d BETH ISRAEL MEDICAL CENTER   (United States)

Author keywords

Cancer; Quality improvement; Substance abuse; Urine toxicology screens

Indexed keywords

ILLICIT DRUG;

ADULT; ARTICLE; CANCER PATIENT; FEMALE; HEALTH CARE QUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PATIENT CARE; PRESCRIPTION; SCREENING TEST; SUBSTANCE ABUSE; URINALYSIS;

ADULT; ETHANOL; FEMALE; HUMANS; MALE; MEDICAL RECORDS; MIDDLE AGED; NEOPLASMS; RETROSPECTIVE STUDIES; SUBSTANCE-RELATED DISORDERS; TOXICOLOGY; URINE;

EID: 0033958822     PISSN: 08853924     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0885-3924(99)00137-2     Document Type: Article

References (17)

1. Sanguineti VR, Samuel SI. Reported prevalence of drug abuse comorbidity in a city-wide emergency rooms system. Am J Drug Alcohol Abuse 1993;19:443-450.
2. Martine GW, Wilkinson DA, Dapur BM. Validation of self-reported cannabis use by urine analysis. Addict Behav 1988;13:147-150.
3. Ney JA, Dooley SL, Keith LG, Chasnoff IJ, Socol ML. The prevalence of substance abuse in patients with suspected preterm labor. Am J Obstet Gynecol 1990;162:1562-1567.
4. Schulman M, Morel M, Karmen A, Chazotte C. Perinatal screening for drugs of abuse: Reassessment of current practice in a high-risk area. Am J Perinatol 1993;10:374-377.
5. Rothstein JL, Levy E, Fecher R, Gordon SK, Bauman WA. Drug use and abuse in an urban veteran spinal cord injured population. J Am Paraplegia Soc 1992;15:217-220.
6. Heinemann AW, Schnoll S, Brandt M, Maltz R, Keen. Toxicology screening in acute spinal cord injury. Alcoholism 1988;12:815-819.
7. Schwartz JG, Zollars PR, Okorodudu AO, Carnahan JJ, Wallace JE, Briggs JE. Accuracy of common drug screen tests. Am J Emerg Med 1991;9:166-170.
8. Albanese MJ, Bartel RL, Bruno RF, Morgenbesser MW, Schatzberg AF. Comparison of measures used to determine substance abuse in an inpatient psychiatric population. Am J Psychiatry 1994;151:1077-1078.
9. Christmas JT, Knisely JS, Dawson KS, Dinsmoor MJ, Weber SI, Schnoll SH. Comparison of questionnaire screening and urine toxicology for detection of pregnancy complicated by substance use. Obstet Gynecol 1992;80:750-754.
10. Horn PT, Mendelsohn J, Bowers MI, Chappen M, Schreier JR, Spalding SH, Weyher J, Berkelhamer JE. Effectiveness of a targeted screening program in identifying infants with positive urine toxicology screening results in a regular neonatal nursery. J Pediatr 1993;123:137-139.
11. Hansen RL, Evans AT, Gillogley KM, Hughes CS, Krener PG. Perinatal toxicology screening. J Perinatol 1992;12:220-224.
12. Schwartz RH. Urine testing in the detection of drugs of abuse. Arch Intern Med 1988;148:2407-2412.
13. Jones DW, Adams D, Martel PA, Rousseau RJ. Drug population in one thousand geographically distributed urine specimens. J Analyt Toxicol 1985;9:125-130.
14. Passik S, Breitbart W, Lowenson J, et al. Use and abuse of opioids and other licit and illicit drugs: Attitudes and behaviors in cancer patients. Proceedings of the Twelfth Annual Scientific Meeting of the American Pain Society, A108.
15. Derogatis L, Morrow G, Fetting J, et al. Prevalence of psychiatric disorders in cancer patients. JAMA 1983;249:751-757.
16. Bruera E, Moyano J, Seifert L, Fainsinger RL, Hanson J, Suarez-Almazor M. The frequency of alcoholism among patients with pain due to terminal cancer. J Pain Symptom Manage 1995;10:599.
17. Passik S, Portenoy R. Substance abuse issues in palliative care. In: Berger A, Portenoy R, Weisin D, eds. Principles and Practice of Palliative Medicine. New York: Lippincott-Raven, 1998.